These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 26119937)
1. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies. Hessmann E; Schneider G; Ellenrieder V; Siveke JT Oncogene; 2016 Mar; 35(13):1609-18. PubMed ID: 26119937 [TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?]. Schneider G; Schmid RM Internist (Berl); 2005 Feb; 46(2):157-65. PubMed ID: 15655682 [TBL] [Abstract][Full Text] [Related]
3. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents. Grippo PJ; Sandgren EP Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988 [TBL] [Abstract][Full Text] [Related]
4. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992 [TBL] [Abstract][Full Text] [Related]
6. Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma. Samuel N; Sayad A; Wilson G; Lemire M; Brown KR; Muthuswamy L; Hudson TJ; Moffat J Pancreas; 2013 Aug; 42(6):1016-26. PubMed ID: 23851435 [TBL] [Abstract][Full Text] [Related]
7. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
8. Kindlin-2 enhances c-Myc translation through association with DDX3X to promote pancreatic ductal adenocarcinoma progression. Liu C; Jiang K; Ding Y; Yang A; Cai R; Bai P; Xiong M; Fu C; Quan M; Xiong Z; Deng Y; Tian R; Wu C; Sun Y Theranostics; 2023; 13(13):4333-4355. PubMed ID: 37649609 [No Abstract] [Full Text] [Related]
9. Opportunities for translation: targeting DNA repair pathways in pancreatic cancer. Maginn EN; de Sousa CH; Wasan HS; Stronach EA Biochim Biophys Acta; 2014 Aug; 1846(1):45-54. PubMed ID: 24727386 [TBL] [Abstract][Full Text] [Related]
10. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes. Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378 [TBL] [Abstract][Full Text] [Related]
11. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173 [TBL] [Abstract][Full Text] [Related]
12. New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma. Mangge H; Niedrist T; Renner W; Lyer S; Alexiou C; Haybaeck J Curr Med Chem; 2017; 24(28):3012-3024. PubMed ID: 28494747 [TBL] [Abstract][Full Text] [Related]
13. Update on the management of pancreatic cancer: surgery is not enough. Ansari D; Gustafsson A; Andersson R World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Nakamoto M; Hisaoka M J UOEH; 2016 Mar; 38(1):1-8. PubMed ID: 26972939 [TBL] [Abstract][Full Text] [Related]
15. Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease. Murphy SJ; Hart SN; Halling GC; Johnson SH; Smadbeck JB; Drucker T; Lima JF; Rohakhtar FR; Harris FR; Kosari F; Subramanian S; Petersen GM; Wiltshire TD; Kipp BR; Truty MJ; McWilliams RR; Couch FJ; Vasmatzis G Cancer Res; 2016 Feb; 76(3):749-61. PubMed ID: 26676757 [TBL] [Abstract][Full Text] [Related]